Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
about
Interleukin 12 deficiency associated with recurrent infectionsIn vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCGA natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunityBiology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27TB vaccine development and the End TB Strategy: importance and current status.Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and BiomarkersSevere infectious diseases of childhood as monogenic inborn errors of immunityInnate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune CellsImmune vulnerability of infants to tuberculosisSTAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesIL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A TherapiesVitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosisMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityBacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesHost immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosisIL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation databaseFirst human model of in vitro Candida albicans persistence within granuloma for the reliable study of host-fungi interactionsInterleukin-22 in kidney injury and regeneration.Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannanA functional candidate screen for coeliac disease genesHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndromeReview of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasisResidual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cellsMice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureusMycobacterium vaccae induces a strong Th1 response that subsequently declines in C57BL/6 miceCompartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosisIncreased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputumSTAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferationTh1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85AIL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and TurkeyGenetic susceptibility to tuberculosis.The TB pandemic: an old problem seeking new solutions.A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.Microbial Disease Spectrum Linked to a Novel IL-12Rβ1 N-Terminal Signal Peptide Stop-Gain Homozygous Mutation with Paradoxical Receptor Cell-Surface ExpressionOptimized expression and specific activity of IL-12 by directed molecular evolution.Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.Paediatric tuberculosis.
P2860
Q22004017-28F70014-515B-4C2E-AF8F-3DDF352D2A92Q24599551-7859955D-E894-4D7D-8BB5-155195A690EBQ24673016-64908F4F-1F4D-491D-BADE-0ED6E907D4A5Q24796992-FA25BCE7-E574-42F1-9698-D0824310C8EBQ26748621-D17A4020-563B-4143-B7C2-4E42615E10F9Q26774207-591ED315-8E54-468A-AED1-5B387348F3BBQ26775891-B6533EA1-8610-4510-AE66-575FBE45B38BQ26799901-140B5F97-B8F1-4910-BD2E-FC9D322C4A92Q26829220-453AAB04-6E5A-40C3-861A-9C5B98A71038Q26829298-2D0C9921-021C-407D-830F-4B3C6EEE4ABEQ26830943-56226FD3-E9A5-4119-9844-FEEE18E0EDDCQ26849410-29218143-E246-453C-9FFE-ABDCBA177CDBQ26862947-E19AF92E-B9A5-41FD-A30A-9863CA7F30D6Q26863260-CBEE48BD-0102-4D2B-BA8A-3A03EB9B9C09Q26863391-4B9D14C0-D38B-40CF-B522-8D36E7D5BDBCQ27022796-17F3201C-F8F6-40CB-9F03-0DABEAA8C28CQ27335343-62092806-85E1-41B5-8BEF-2E7F1CDC4FA6Q27687335-10B1C33E-9635-4736-897B-B21B05670434Q28235685-D140E6A0-8376-4D96-B952-B1B397BB1A69Q28251539-380B3985-6314-4819-9FF3-2A6000A58492Q28266613-D3123E4A-50BA-470E-8262-9C3AD22B3834Q28280687-3BF63DF6-DEE9-4377-8589-52F32B08C885Q28344650-0403E8AE-34A3-45F0-8543-8B61BFCE739FQ28347466-718A847B-D806-4DE0-9413-94E0650A36C2Q28356383-04FB24D7-FBF8-479D-A0E2-82AF11F29B97Q28387743-79FD7F03-F7B1-48FC-91A9-EBCDD86E520AQ28395969-B34E692D-70FE-463E-8DDA-2FE3831BB3A1Q28590165-0E8359D7-BF98-4C80-B247-FD43329F4ADCQ28740954-37BBFEEC-A466-4D45-B7A5-509AD4C74017Q28741093-4C3CD8E5-F046-48CE-99A4-CF3B49710293Q30332232-AA5C1E6E-27B8-4C4E-B432-2C1A3136E750Q30360726-DDA64EAB-559A-478C-8500-4CD8E82FCEABQ30492620-00168B69-40C8-4DD4-B121-069C61E98E5CQ30833475-E0D60A0D-8F39-4196-8C71-6C5FC42F44C6Q30845113-5D8DFD1C-A025-4EB7-AFB2-12681A75F12EQ33185720-A7C0C4D8-B65C-4A3D-9CA8-F3565F2255CAQ33222437-10B59233-EBFC-44E5-B23A-7EC4F83ACFE2Q33255341-D27B4F37-9E34-43DE-B895-E01F0B323362Q33265416-2D441622-01A6-4E04-A86D-8C7BBC51811CQ33581724-F21B55C3-53CE-49A9-85B2-3B158288B760
P2860
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@ast
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@en
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@nl
type
label
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@ast
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@en
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@nl
prefLabel
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@ast
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@en
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@nl
P2093
P50
P1433
P1476
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
@en
P2093
Bernaudin F
Drysdale P
Döffinger R
Jeppsson O
Kumararatne D
Lamhamedi S
P304
P356
10.1126/SCIENCE.280.5368.1432
P407
P577
1998-05-01T00:00:00Z